Alterations of KCl- and ATP-induced increase in [Ca2+](i) in cardiomyocytes from vitamin B6 deficient rats

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 9, 1998, Pages 837-842

  Dakshinamurti, Krishnamurti ^a   Wang, Xi ^b   Musat, Sorin ^b   Dandekar, Masumi ^b   Dhalla, Naranjan S ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Ca2+ handling in heart; Myocardial purinergic receptors; Rat cardiomyocytes; Vitamin B6 deficiency

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; HOMOCYSTEINE; POTASSIUM CHLORIDE; PURINE RECEPTOR; PYRIDOXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CALCIUM METABOLISM; CELL FUNCTION; CONTROLLED STUDY; FLUORESCENCE; HEART MUSCLE CELL; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; RAT; SARCOLEMMA; SIGNAL TRANSDUCTION;

EID: 0032468790     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y98-078     Document Type: Article

References (33)

1. Aybak, M., Sermet, A., Ayyildiz, M.O., and Karakilcik, A.Z. 1995. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Drug Res. 45: 1271-1273.
2. Brophy, M.H., and Siiteri, P.K. 1975. Pyridoxal phosphate and hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 121: 1075-1079.
3. Burnstock, G. 1993. Physiological and pathophysiological roles of purines: an update. Drug Dev. Res. 28: 195-206.
4. Carafoli, E. 1987. Intracellular calcium homeostasis. Annu. Rev. Biochem. 56: 395-433.
5. 6 and risk of myocardial infarction in US physicians. J. Am. Coll. Nutr. 15: 136-143.
6. 2+ concentration in isolated rat ventricular myocytes. J. Physiol. (London), 445: 369-388.
7. Dakshinamurti, K., and Stephens, M.C. 1969. Pyridoxine deficiency in the neonate rat. J. Neurochem. 16: 1515-1522.
8. Danziger, R.S., Raffoeli, S., Moreno-Sanchez, R., Sakai, M., Capogrossi, M.C., Spurgeon, H.A., Honsford, R.G., and Lakatta, E.G. 1988. Extracellular ATP has a potent effect to enhance cytosolic calcium and contractility in single ventricular myocytes. Cell Calcium, 9: 193-199.
9. 2+. Am. J. Physiol. 257: C750-C758.
10. Dhalla, N.S., Wang, X., and Beamish, R.E. 1996. Intracellular calcium handling in normal and failing hearts. Exp. Clin. Cardiol. 1: 7-20.
11. Dhalla, N.S., Wang, X., Sethi, R., Das, P.K., and Beamish, R.E. 1997. β-Adrenergic linked signal transduction mechanisms in failing hearts. Heart Fail. Rev. 2: 55-65.
12. 6. Res. Commun. Mol. Pathol. Pharmacol. 89: 208-220.
13. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
14. Harker, L.A., Ross, R., Slichter, S.J., and Scott, R.C. 1976. Homocysteine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 58: 731-741.
15. 6 and coronary artery diseases risk. J. Am. Coll. Nutr. 15: 109-110.
16. Kleiger, J.A., Altshuler, C.H., Krakow, G., and Hollister, C. 1969. Abnormal pyridoxine metabolism in toxemia of pregnancy. Ann. N.Y. Acad. Sci. 166: 288-296.
17. 6 status in patients with acute myocardial infarction. Am. J. Cardiol. 63: 513-516.
18. 6. Clin. Exp. Hypertens. 15: 489-500. [Abstr.]
19. 6 on the systolic blood pressure of rats in various animal models of hypertension. J. Hypertens. 14: 355-363.
20. McCully, K.S., and Wilson, R.B. 1975. Homocysteine theory of atherosclerosis. Atherosclerosis, 22: 215-227.
21. Michel, A.D., Grahames, C.B., and Humphrey, P.P. 1996. Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx. Naunyn-Schmiedebergs Arch. Pharmacol. 354: 562-571.
22. Murray, J.C., Fraser, D.R., and Levene, C.I. 1978. The effect of pyridoxine on lysyl oxidase activity in the chick. Exp. Mol. Pathol. 28: 301-308.
23. 2+ in rat cardiomyocytes. Cardiovasc. Pathobiol. 1: 152-159.
24. Paulose, C.S., Dakshinamurti, K., Packer. S., and Stephens, N.L. 1988. Sympathetic stimulation and hypertension in pyridoxine-deficient adult rat. Hypertension (Dallas), 11: 387-391.
25. Rhinehart, J.F., and Greenberg, L.D. 1949. Arteriosclerotic lesions in pyridoxine deficient monkeys. Am. J. Pathol. 25: 481-491.
26. Serfontein, W.J., Ubbink, J.B., De Villiers, L.S., Rapley, C.H., and Becker, P.J. 1985. Plasma pyridoxal-5′-phosphate level as risk index for coronary heart disease. Atherosclerosis, 55: 357-361.
27. 6, and folate nutritional status in men hyperhomocysteinemia. Am. J. Clin. Nutr. 57: 47-53.
28. 6 and coronary artery disease. Epidemiological observations and case studies. Atherosclerosis, 63: 235-238.
29. Viswanathan, M., Paulose, C.S., Lak, K.J., Sharma, S.K., and Dakshinamurti, K. 1990. Alterations in brain stem alpha 2 adrenoceptors and activity in pyridoxine-deficient rat model of hypertension. Neurosci. Lett. 111: 201-205.
30. i in cardiocytes by pyridoxal 5-phosphate. J. Mol. Cell. Cardiol. 28: A181.
31. 2+ and cardiac contractile force. Am. J. Physiol. 271: H651-H659.
32. 2+ mobilization by extracellular ATP in rat cardiac myocytes: regulation by protein kinases C and A. Am. J. Physiol. 263: C933-C940.
33. 35S]ATP S binding sites in the purified heart sarcolemma membrane. Am. J. Physiol. 258: C185-C188.